On April 10, 2025, NextCure, Inc. updated its corporate presentation regarding its ongoing clinical trial of LNCB74 and will engage with the investment community using these materials.
AI Assistant
NEXTCURE INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.